Skip to content

Study of the Sensitivity of Manual vs Electric Aspiration to Detect Completed Early Abortion

The Sensitivity of Manual Versus Electric Vacuum Aspiration to Detect Completed Abortion at Less Than Six Weeks of Pregnancy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01085825
Enrollment
500
Registered
2010-03-12
Start date
2010-04-30
Completion date
Unknown
Last updated
2017-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced Abortion

Keywords

induced abortion, termination of pregnancy, manual vacuum aspiration, electric vacuum aspiration

Brief summary

With sensitive urine pregnancy tests, women are now able to confirm very early pregnancies. However, approximately one third of abortion facilities do not offer abortions at less than six weeks of pregnancy. Providers may be concerned that they will be unable to identify products of conception (POCs) in uterine aspirates after early abortion and about the time, cost and risk associated with following serum hCG levels when completed abortion cannot be confirmed by gross inspection. Many providers believe that manual vacuum aspiration (MVA) causes less destruction of pregnancy tissue and therefore may increase the likelihood of identifying POCs on gross inspection. No published reports specifically compare MVA to electric vacuum aspiration (EVA) for the detection of complete products of conception and none compare MVA and EVA at less than 6 weeks of pregnancy. We, the investigators, propose to conduct a randomized controlled trial comparing the sensitivity of MVA to EVA for the detection of completed abortion in 500 women with pregnancies of less than 6 weeks gestation at a large inner city family planning center. We will measure positive identification of POCs on gross inspection in patients subsequently shown to have completed abortions. We hypothesize that the rate of true positive detection of POCs will be higher in dilation and curettage (D&C) using MVA than EVA.

Interventions

PROCEDURED & C abortion

Participants will be randomized to receive their abortion using either manual vacuum aspiration or electric vacuum aspiration.

Sponsors

Society of Family Planning
CollaboratorOTHER
Planned Parenthood of Greater New York
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* gestational sac size \<12 mm or no visible sac (with positive pregnancy test) day of surgical abortion * no medical contraindications to outpatient abortion at study site

Exclusion criteria

* not able to consent * suspected ectopic pregnancy (pelvic mass, unilateral pain, or detection on ultrasound), suspected molar pregnancy, or no sac and vaginal bleeding suspicious for completed spontaneous abortion * failed medication abortion

Design outcomes

Primary

MeasureTime frameDescription
Accurate Confirmation of Completed Abortion2 weeks - 6 monthsAccurate confirmation of completed abortion, as determined by urine pregnancy test at following, appropriately falling serum hCG levels, or patient report of returned menses

Countries

United States

Participant flow

Recruitment details

We enrolled a total of 500 women from April 22, 2010 to October 14, 2011; 252 women were randomized to MVA and 248 to EVA.

Participants by arm

ArmCount
Manual Vacuum Aspiration
D & C abortion: Participants will be randomized to receive their abortion using either manual vacuum aspiration or electric vacuum aspiration.
252
Electric Vacuum Aspiration
D & C abortion: Participants will be randomized to receive their abortion using either manual vacuum aspiration or electric vacuum aspiration.
248
Total500

Baseline characteristics

CharacteristicManual Vacuum AspirationElectric Vacuum AspirationTotal
Age, Continuous25.3 years
STANDARD_DEVIATION 5
25.4 years
STANDARD_DEVIATION 5
25.4 years
STANDARD_DEVIATION 5
Gender
Female
252 Participants248 Participants500 Participants
Gender
Male
0 Participants0 Participants0 Participants
Mean sac diameter8.0 mm
STANDARD_DEVIATION 2.4
7.8 mm
STANDARD_DEVIATION 2.3
7.9 mm
STANDARD_DEVIATION 2.3

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 2520 / 248
serious
Total, serious adverse events
0 / 2520 / 248

Outcome results

Primary

Accurate Confirmation of Completed Abortion

Accurate confirmation of completed abortion, as determined by urine pregnancy test at following, appropriately falling serum hCG levels, or patient report of returned menses

Time frame: 2 weeks - 6 months

ArmMeasureValue (NUMBER)
Manual Vacuum AspirationAccurate Confirmation of Completed Abortion182 participants
Electric Vacuum AspirationAccurate Confirmation of Completed Abortion164 participants
p-value: 0.13Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026